Apoptosis mediators fasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS

Huang W-X1, M P Huang, M A Gomes

  • 1Department of Neurology, Karolinska Institute at Huddinge University Hospital, Sweden. Wen-xin.Huang@neurotec.ki.se

Neurology
|November 4, 2000
PubMed
Abstract

Insights

This study found increased expression of Fas ligand (FasL) and TNF-related apoptosis-inducing ligand (TRAIL) in patients with multiple sclerosis (MS). Further research is needed to determine if this impacts the autoimmune process in MS.

Area of Science:

  • Immunology
  • Neuroscience
  • Molecular Biology

Background:

  • Dysregulation of apoptosis, a key process in immune cell regulation, is implicated in autoimmune diseases like multiple sclerosis (MS).
  • Inadequate apoptosis may lead to the persistence of autoreactive immune cells, contributing to MS pathogenesis.

Purpose of the Study:

  • To investigate the expression levels of apoptosis-inducing ligand and receptor molecules in individuals diagnosed with MS.
  • To explore the role of apoptosis-related molecules in the context of MS.

Main Methods:

  • Quantification of messenger RNA (mRNA) for Fas ligand (FasL), TNF-related apoptosis-inducing ligand (TRAIL), and their receptors (Fas, TRAIL-R2) using competitive reverse transcription PCR.
  • Analysis was performed on peripheral blood mononuclear cells from 47 untreated MS patients and 46 healthy controls.

Main Results:

  • Significantly increased expression of FasL mRNA was observed in MS patients, particularly in the relapsing-remitting MS subgroup during remission.
  • TRAIL mRNA levels were also upregulated in MS patients compared to controls, with no significant differences between clinical subgroups.
  • TRAIL-R2 expression was slightly elevated in MS patients, while Fas expression remained similar between groups. Differences in TRAIL-R2 isoforms (TRICK2a/TRICK2b) were noted in MS patients.

Conclusions:

  • Peripheral blood lymphocytes in MS patients exhibit elevated expression of FasL and TRAIL.
  • The clinical significance of this increased expression requires further investigation to ascertain if it promotes autoimmunity or acts as a compensatory anti-inflammatory mechanism.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.